In IBD, the production of cytokines and other pro-inflammatory mediators, the progression of UC and CD, disruption of the epithelial barrier and a higher histopathological score have been attributed to activation of the NF-κB signalling pathway [35]. This evidence concerns the gene NFKB1 and inflammatory bowel disease.